España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
PolyPid
PYPD
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.99
-0.01000
-0.33%
At close: -
$2.75
-0.24
-8.03%
After Hours: Feb 14, 8:07 AM EDT
Get Report
Comment
PolyPid (PYPD) Forecast
News
Earnings
PolyPid (PYPD) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for PolyPid (NASDAQ:PYPD) Stock
PolyPid Stock (NASDAQ: PYPD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, February 12, 2025
PolyPid Q4 2024 GAAP EPS $(1.13) Misses $(0.8...
Benzinga Newsdesk
Earnings Scheduled For February 12, 2025
Benzinga Insights
Tuesday, January 21, 2025
PolyPid Files For Resale Of Up To 11.23M Ordi...
Benzinga Newsdesk
Thursday, December 26, 2024
Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on PolyPid,...
Benzinga Newsdesk
Tuesday, December 24, 2024
Reported Earlier, PolyPid's SHIELD II Trial R...
Benzinga Newsdesk
Monday, December 16, 2024
HC Wainwright & Co. Reiterates Buy on PolyPid...
Benzinga Newsdesk
Wednesday, December 11, 2024
PolyPid shares are trading higher after the c...
Benzinga Newsdesk
Polypid Announced A New Research And Developm...
Benzinga Newsdesk
Friday, November 29, 2024
PolyPid Receives Non-Compliance Letter From N...
Benzinga Newsdesk
Wednesday, November 13, 2024
PolyPid Q3 2024 GAAP EPS $(1.22) Misses $(0.9...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2024
Benzinga Insights
Tuesday, November 12, 2024
PolyPid's Earnings: A Preview
Benzinga Insights
Monday, November 04, 2024
Craig-Hallum Initiates Coverage On PolyPid wi...
Benzinga Newsdesk
Monday, October 21, 2024
PolyPid Announced A Publication In The Intern...
Benzinga Newsdesk
Wednesday, October 02, 2024
HC Wainwright & Co. Reiterates Buy on PolyPid...
Benzinga Newsdesk
Tuesday, October 01, 2024
PolyPid Completes Enrollment for SHIELD II In...
Benzinga Newsdesk
Friday, August 30, 2024
PolyPid Files For Resale Of Up To 3.9M Ordina...
Benzinga Newsdesk
Thursday, August 15, 2024
HC Wainwright & Co. Reiterates Buy on PolyPid...
Benzinga Newsdesk
Wednesday, August 14, 2024
PolyPid Q2 2024 GAAP EPS $(1.25) Misses $(1.1...
Benzinga Newsdesk
Friday, August 02, 2024
Reported Earlier, PolyPid Secures Up To $14M ...
Benzinga Newsdesk
Monday, July 29, 2024
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Tuesday, July 02, 2024
Polypid Files For Ordinary Shares Offering Of...
Benzinga Newsdesk
Tuesday, June 18, 2024
PolyPid Updates On SHIELD II Trial Amidst KOL...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on PolyPid...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on PolyPid...
Benzinga Newsdesk
Wednesday, May 08, 2024
PolyPid Q1 2024 GAAP EPS $(1.37) Beats $(1.58...
Benzinga Newsdesk
Wednesday, May 01, 2024
HC Wainwright & Co. Reiterates Buy on PolyPid...
Benzinga Newsdesk
Friday, March 01, 2024
PolyPid Ltd. 13G Filing Shows Rosalind Advis...
Benzinga Newsdesk
Wednesday, February 14, 2024
PolyPid Q4 EPS $(3.97) Misses $(3.58) Estimat...
Benzinga Newsdesk
Earnings Scheduled For February 14, 2024
Benzinga Insights
Monday, February 12, 2024
PolyPid Reports Enrollment Of The 100th Patie...
Benzinga Newsdesk
Friday, January 05, 2024
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
PolyPid shares are trading higher. The compan...
Benzinga Newsdesk
Thursday, January 04, 2024
PolyPid Announces $16.2M Private Placement Of...
Benzinga Newsdesk
Wednesday, November 08, 2023
PolyPid Q3 EPS $(3.40) Beats $(4.16) Estimate...
Benzinga Newsdesk
Earnings Scheduled For November 8, 2023
Benzinga Insights
Tuesday, November 07, 2023
PolyPid's Earnings: A Preview
Benzinga Insights
Monday, October 23, 2023
Barclays Maintains Equal-Weight on PolyPid, R...
Benzinga Newsdesk
Thursday, October 12, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2023
Benzinga Insights
HC Wainwright & Co. Initiates Coverage On Pol...
Benzinga Newsdesk
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, October 04, 2023
PolyPid Announces Publication of Preclinical ...
Benzinga Newsdesk
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, September 28, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, September 27, 2023
Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
PolyPid Announces Successful Commercial Good ...
Benzinga Newsdesk
Wednesday, September 20, 2023
PolyPid Announces 1-For-30 Reverse Share Spli...
Benzinga Newsdesk
Show More
